John Kinney is the CEO of Validus Pharmaceuticals. His experience over the last 25 years includes roles in commercial strategy, sales and marketing, franchise management, operations, and finance. Prior to joining Validus, John has held franchise head and strategic marketing positions at Sandoz, Mylan, Genentech, and Roche – leading franchise and brand teams as well as implementing strategic turnarounds in the areas of Anti-infectives, Diabetes, Anesthesia, Metabolic, Hepatitis, HIV, Influenza and Oncology. John has also been a senior leader in the management consulting practice at PwC for Life Sciences, focusing on new launches, commercial effectiveness, patient engagement, due diligence evaluation, and post merger integration. John has an MBA from NYU’s Stern School of Business, a Masters in Biology from Seton Hall University, and a BS in Chemistry from the Pennsylvania State University.
Richard Post is Vice President, Sales and Marketing of Validus Pharmaceuticals. He has over 25 years of experience in the pharmaceutical industry, most recently serving as Sales Director for the Eastern Region, Specialized Markets at Solvay Pharmaceuticals. While at Solvay, Post also held positions in mental health, gastroenterology, and women’s health regional marketing, training & development, and field sales. Prior to entering the pharmaceutical industry, he held various positions in secondary education as a high school guidance counselor and English teacher. Post received his BA in English from Simpson College, Iowa, and his Masters of Education from Rutgers University.